Searchable abstracts of presentations at key conferences in endocrinology

ea0081p50 | Calcium and Bone | ECE2022

Impact of chronic hypoparathyroidism on symptom severity and interference with life as reported by patients treated with recombinant human parathyroid hormone (1-84), rhpth(1-84)

Clarke Bart L. , Hadker Nandini , Athavale Amod , Kolev Irana , Ayodele Olulade

Chronic hypoparathyroidism is a rare mineral homeostasis disorder managed by conventional therapy (oral calcium and active vitamin D), alone or with adjunctive rhPTH(1-84). Chronic hypoparathyroidism is associated with considerable symptom burden, which can interfere with daily living. We report results from a web-based, cross-sectional survey conducted among adults with chronic hypoparathyroidism. The objectives were to quantify the impact on overall life interference of (1) ...

ea0056gp176 | Parathyroid | ECE2018

Symptom burden and HRQoL reported among patients with chronic hypoparathyroidism: impact of treatment with rhPTH (1-84) and with standard therapy

Chen Kristina , Hadker Nandini , Abibova Irana , Hanbury-Brown Lachlan , Vera-Llonch Montserrat , Clarke Bart

Chronic hypoparathyroidism (HypoPT) is a rare disease associated with a variety of symptoms and diminished health-related quality of life (HRQoL). This study aimed to characterise and quantify the symptom burden, HRQoL, and overall disease impact in patients receiving recombinant human parathyroid hormone (rhPTH1-84, Natpar®) for inadequately controlled HypoPT and in symptomatic patients receiving standard therapy (ST; calcium and/or vitamin D supplements). A w...